Showing 1441-1450 of 1842 results for "".
Is an Optometric Externship Program Right for Your Practice?
https://modernod.com/topics/business/is-an-optometric-externship-program-right-for-your-practice/38658/Consider the pros and cons presented here to help you decide.Myth-Busting the 20/20/20 Rule
https://modernod.com/topics/myopia/myth-busting-the-202020-rule/38651/Many regularly recommend this guideline to patients, but what do the data actually say about it?Retina Therapeutic Roundup
https://modernod.com/topics/retina/retina-therapeutic-roundup/38526/An overview of promising new drugs targeting diseases that threaten the sight of our patients.Gene Therapy and Inherited Retinal Disease
https://modernod.com/mod-issues/2022-mar/gene-therapy-and-inherited-retinal-disease/38393/Optometry plays a vital role in the management of patients with genetic eye conditions.Strategies for the Successful Perioperative Management of OSD
https://modernod.com/topics/ocular-surface/strategies-for-the-successful-perioperative-management-of-osd/38310/To avoid surprises after cataract or refractive surgery, stabilize the ocular surface first.Corneal Dystrophies 101
https://modernod.com/topics/ocular-surface/corneal-dystrophies-101/38218/A brief review for the practitioner most likely to encounter these conditions.CXL: What It Is, and When to Refer
https://modernod.com/mod-issues/2020-mar/cxl-what-it-is-and-when-to-refer/39098/A US clinical trial of epi-on corneal collagen crosslinking is expected to be completed this year.Ophthalmic Drug Delivery: History, Status, and Trends for the Future
https://modernod.com/mod-issues/2019-nov-dec/ophthalmic-drug-delivery-history-status-and-trends-for-the-future/39093/It’s been a long road, and there is much farther to go.Multifocal IOLs: What Have We Learned?
https://modernod.com/mod-issues/2019-sept/multifocal-iols-what-have-we-learned/39079/A lot has been revealed since the earliest studies in the 1980s.2024 in Review: FDA Approvals and Product Launches
https://modernod.com/mod-issues/2025-jan-feb/2024-in-review-fda-approvals-and-product-launches/38933/An overview of new optometric medications and technologies to know about.